Business Today
Subscribe
PMS TodayBudget 2025US NewsIndiaWeatherBT ShortsNRIEducationElection
BT GolfBT India 100BT Mindrush
Search
Advertisement
Business News
markets
stocks
Morepen Laboratories Ltd
Morepen Laboratories Ltd

Morepen Laboratories Ltd (MOREPENLAB) Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 11,23,741
Dec 05, 2025
  • NSE
  • BSE
Share
  • Whatsapp
  • Twitter
  • Facebook
₹42.47
₹-0.98 (-2.26%)
42.37Low
Today’s Performance
43.43High
42.00Low
52 Week’s Performance
91.70High

bt_logoStock Analysis

bt_logoStock Performance

  • 1 Day-2.26%
  • 1 Week-2.14%
  • 1 Month-10.53%
  • 3 Months-13.87%
  • 6 Months-34.12%
  • 1 Year-50.83%
  • 3 Years10.12%
  • 5 Years4.40%

bt_logoStock Summary

  • Face Value (₹)2.00
  • Beta1.91
  • 52-Week Low (₹)42.00
  • 52-Week High (₹)91.70
  • Price-to-Book (X)*1.99
  • Dividend Yield (%)0.46
  • Price-to-Earnings (P/E) (X)*24.01
  • Earnings Per Share (₹)1.81
  • Market Cap (₹ Cr.)*2,380.86
* Values as of last close price

bt_logoCOMPETITORS

BT TV

India–Russia Trade to Cross $100 Billion Before 2030: PM Modi Fast-Tracks Economic Partnership2:31India–Russia Trade To Cross $100 Billion Before 2030: PM Modi Fast-Tracks Economic Partnership
Russia Eyes Indian Workforce, New Trade Plan And Tariff Cuts In Major Economic Push11:22Russia Eyes Indian Workforce, New Trade Plan And Tariff Cuts In Major Economic Push
IndiGo CEO Pieter Elbers Admits Worst-Ever Disruption As Over 1,000 Flights Cancelled Nationwide3:48IndiGo CEO Pieter Elbers Admits Worst-Ever Disruption As Over 1,000 Flights Cancelled Nationwide
India & Russia Plan Faster Trade Routes, Digital Corridors & New Nuclear Opportunities2:42India & Russia Plan Faster Trade Routes, Digital Corridors & New Nuclear Opportunities
Passengers Angry Over IndiGo Delays, Complain Of No Information3:16Passengers Angry Over IndiGo Delays, Complain Of No Information
Vikram Misri: India–Russia to Accelerate FTA, Investment Treaty and Key Connectivity Negotiations1:58Vikram Misri: India–Russia To Accelerate FTA, Investment Treaty And Key Connectivity Negotiations
‘If US Can Buy Russian Fuel, Why Not India?’: Putin Challenges Trump’s Claim On Ukraine War3:01‘If US Can Buy Russian Fuel, Why Not India?’: Putin Challenges Trump’s Claim On Ukraine War
IndiGo Flight Chaos: Delhi Airport Meltdown, DGCA Relaxes Crew Rostering Restrictions8:35IndiGo Flight Chaos: Delhi Airport Meltdown, DGCA Relaxes Crew Rostering Restrictions
Why InCred’s Healthcare Fund Is On Fire, Aditya Khemka Decodes29:01Why InCred’s Healthcare Fund Is On Fire, Aditya Khemka Decodes
Big RBI Move! ₹1.5 Lakh Crore Liquidity Surplus & Cheaper Loans | 78 bps Rate Drop2:39Big RBI Move! ₹1.5 Lakh Crore Liquidity Surplus & Cheaper Loans | 78 bps Rate Drop
View more

bt_logoFAQ's

What was Morepen Laboratories Ltd share price previously?
Morepen Laboratories Ltd share price was down by -2.26% from the previous closing price of ₹43.45.
Who are peers of Morepen Laboratories Ltd?
The peers of Morepen Laboratories Ltd are Sun Pharmaceutical Industries Ltd, Divis Laboratories Ltd, Torrent Pharmaceuticals Ltd, Cipla Ltd, Dr Reddys Laboratories Ltd, Lupin Ltd, Zydus Lifesciences Ltd.
Who is/are the promoter/promoters of Morepen Laboratories Ltd?
The promotor/promotors of Morepen Laboratories Ltd are Sushil Suri, Vipul Kumar Srivatava, Sanjay Suri, Praveen Kumar Dutt, Savita, Sharad Jain.
What has been 52-week high of Morepen Laboratories Ltd stocks?
The highest price of Morepen Laboratories Ltd stock is ₹91.70 in the last 52-week.
What is the share price of Morepen Laboratories Ltd (MOREPENLAB) today on NSE?
As on Dec 05, 2025 Morepen Laboratories Ltd (MOREPENLAB)’s share price on NSE is Rs 42.47
What is the market cap of Morepen Laboratories Ltd (MOREPENLAB)?
The current market capitalisation of Morepen Laboratories Ltd (MOREPENLAB) is 2,380.86 crores
What is Morepen Laboratories Ltd Share symbol?
The symbol of Morepen Laboratories Ltd is MOREPENLAB.
What is the PE ratio of Morepen Laboratories Ltd (MOREPENLAB)?
The current PE ratio of Morepen Laboratories Ltd (MOREPENLAB) is 24.01.
What is the PB ratio of Morepen Laboratories Ltd (MOREPENLAB)?
The current PB ratio of Morepen Laboratories Ltd (MOREPENLAB) is 1.99.
Today’s High & Low share prices of Morepen Laboratories Ltd (MOREPENLAB) on NSE?
Today, the share price of Morepen Laboratories Ltd (MOREPENLAB) on NSE touched a high of Rs 43.43 and a low of Rs 42.37
What price did Morepen Laboratories Ltd (MOREPENLAB) shares open on the NSE today?
On NSE, the share price of Morepen Laboratories Ltd (MOREPENLAB) opened at Rs 43.43
What is the 52-week high of Morepen Laboratories Ltd (MOREPENLAB)?
The 52-week high price of Morepen Laboratories Ltd (MOREPENLAB) is Rs 91.70
What is the 52-week low of Morepen Laboratories Ltd (MOREPENLAB)?
The 52-week low price of Morepen Laboratories Ltd (MOREPENLAB) is Rs 42.00

bt_logoAbout Morepen Labs.

Morepen Laboratories Ltd, incorporated in the year 1984, has its registered office in Morepen Village, Nalagarh Road Near Baddi, Solan, Himachal Pradesh, 173205, 91-01795-276201-03, 91-01795-276204. The main industry in which Morepen Laboratories Ltd operates is Pharmaceuticals - Indian - Bulk Drugs & Formln.

Auditor/Auditors for Morepen Laboratories Ltd is/are S P Babuta & Associates. In the main management, Sushil Suri is chairman and Vipul Kumar Srivatava is the company secretary for Morepen Laboratories Ltd.

  • SS
    Sushil SuriChairman & Managing Director
  • VKS
    Vipul Kumar SrivatavaCompany Sec. & Compli. Officer
  • SS
    Sanjay SuriWhole-time Director
  • PKD
    Praveen Kumar DuttNon Executive & Independent Director
  • S
    SavitaNon Executive & Independent Director
  • SJ
    Sharad JainIndependent Director

bt_logoTop Stories

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.